Ga-68 PSMA-11 impacting prostate cancer management in a real-world setting: A pilot experience using the total-body PET/CT scanner. Real-world treatment patterns and progression-free survival among ...
SANTA BARBARA, Calif. and STOCKHOLM, Sweden, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Palette Life Sciences (“Palette”), a global medical device company dedicated to improving prostate radiation therapy ...
Response evaluation criteria in PSMA PET/CT (RECIP 1.0) in metastatic castration-resistant prostate cancer. Prognostic value of artificial intelligence (AI) –driven tumor estimation of PSMA PET total ...
With a price-to-earnings multiple under 15x and its relative strength index below 40, Lantheus Holdings, Inc. (NASDAQ:LNTH) secures a spot on our list of the 13 Oversold Value Stocks to Invest in Now.
A combined PSMA-PET/MRI scanner better detected clinically significant prostate cancer in men on active surveillance. The addition of piflufolastat F18 (18 F-DCFPyL) prostate-specific membrane antigen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results